Navigation Links
Study reveals improved prediction of prostrate cancer
Date:1/30/2008

Scientists are another step closer to understanding why some people suffer from life-threatening diseases such as cancer. Research published in the new online open access journal BMC Medical Genomics reveals a model that may enable more accurate prediction of the risk of prostate cancer progression. By combining the Gleason score (a pathological score given to prostate cancer based on its microscopic appearance) with structured data from biomarker assessments, the researchers have developed a model for predicting the likelihood of prostate cancer virulence.

The research team from the University of Texas M. D. Anderson Cancer Center, led by Dr. Timothy McDonnell, used tissue microarrays with specimens covering the spectrum of low to high grade prostate cancer, to address several questions of clinical and pathological interest. The biomarkers evaluated in this study comprised well-characterized cell cycle and cell death regulators known to be variably expressed by prostate cancers. Significant differences in the molecular signatures were found among these varying grades of tumors, and a biostatistical model was developed using a limited number of molecular markers to enable a more accurate prediction of the risk of prostate cancer progression.

We believe these findings will be of potential benefit to a substantial portion of the patient population diagnosed with early prostate cancer by providing valuable information regarding the risk of disease progression says McDonnell. With this type of information patients could be more appropriately managed based on their individual risk profile.

Healthcare professionals are increasingly turning to the use of genomic techniques to understand why some people are predisposed to certain conditions such as infections, addictions, and illnesses like diabetes, heart disease, and schizophrenia, while others are not. By employing these techniques, researchers and physicians could soon offer patients a more tailored and individual medical treatment program. The launch of the open access journal BMC Medical Genomics gives these professionals immediate and free access to research articles, aiding in the development of new and better ways to improve health and prevent diseases.

Publisher BioMed Central recognizes that genomic approaches to medicine will contribute greatly to the delivery of personalized medical treatment in the future and allow a better understanding of the molecular basis of diseases. The publisher is committed to being at the forefront of research published in the field of genomics, with developments in genome-scale population genetics, epigenetics, personalized medicine and pharmacogenomics all planned for the future.


'/>"/>

Contact: Charlotte Webber
press@biomedcentral.com
44-020-763-19980
BioMed Central
Source:Eurekalert

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical ... the primary prevention of cardiovascular diseases during the 15th Annual Women’s Health ...
(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Restoration, has recently contributed a medical article to the newly revamped Cosmetic ... Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... , and named its founder as Diplomat,s chief information ... Tennessee , will operate under Diplomat subsidiary Envoy ... for health care partners to include IT outsourcing, consulting, ... "In an interoperable world, technology delivers comprehensive insight and ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology: